Polli JE - Search Results

1

The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.

Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, Martinez MN, Lennernäs H, Wigal TL, Swinney DC, Polli JE, Serajuddin ATM, Cook JA, Dressman JB. Selen A, et al. Among authors: polli je. J Pharm Sci. 2014 Nov;103(11):3377-3397. doi: 10.1002/jps.24162. Epub 2014 Sep 24. J Pharm Sci. 2014. PMID: 25256402 Review.

2

Novel approach to the analysis of in vitro-in vivo relationships.

Polli JE, Crison JR, Amidon GL. Polli JE, et al. J Pharm Sci. 1996 Jul;85(7):753-60. doi: 10.1021/js9503587. J Pharm Sci. 1996. PMID: 8819002

3

Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.

Polli JE, Rekhi GS, Augsburger LL, Shah VP. Polli JE, et al. J Pharm Sci. 1997 Jun;86(6):690-700. doi: 10.1021/js960473x. J Pharm Sci. 1997. PMID: 9188051

4

Effect of common excipients on Caco-2 transport of low-permeability drugs.

Rege BD, Yu LX, Hussain AS, Polli JE. Rege BD, et al. Among authors: polli je. J Pharm Sci. 2001 Nov;90(11):1776-86. doi: 10.1002/jps.1127. J Pharm Sci. 2001. PMID: 11745735

5

Biopharmaceutics classification system: the scientific basis for biowaiver extensions.

Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, Shah VP, Lesko LJ, Chen ML, Lee VH, Hussain AS. Yu LX, et al. Among authors: polli je. Pharm Res. 2002 Jul;19(7):921-5. doi: 10.1023/a:1016473601633. Pharm Res. 2002. PMID: 12180542 Free article.

6

Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport.

Tolle-Sander S, Grill A, Joshi H, Kapil R, Persiani S, Polli JE. Tolle-Sander S, et al. Among authors: polli je. J Pharm Sci. 2003 Oct;92(10):1968-80. doi: 10.1002/jps.10428. J Pharm Sci. 2003. PMID: 14502537

7

Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities.

Polli JE, Yu LX, Cook JA, Amidon GL, Borchardt RT, Burnside BA, Burton PS, Chen ML, Conner DP, Faustino PJ, Hawi AA, Hussain AS, Joshi HN, Kwei G, Lee VH, Lesko LJ, Lipper RA, Loper AE, Nerurkar SG, Polli JW, Sanvordeker DR, Taneja R, Uppoor RS, Vattikonda CS, Wilding I, Zhang G. Polli JE, et al. Among authors: polli jw. J Pharm Sci. 2004 Jun;93(6):1375-81. doi: 10.1002/jps.20064. J Pharm Sci. 2004. PMID: 15124197 No abstract available.

8

Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.

Balakrishnan A, Rege BD, Amidon GL, Polli JE. Balakrishnan A, et al. Among authors: polli je. J Pharm Sci. 2004 Aug;93(8):2064-75. doi: 10.1002/jps.20118. J Pharm Sci. 2004. PMID: 15236455

9

Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Khandelwal A, Bahadduri PM, Chang C, Polli JE, Swaan PW, Ekins S. Khandelwal A, et al. Among authors: polli je. Pharm Res. 2007 Dec;24(12):2249-62. doi: 10.1007/s11095-007-9435-9. Epub 2007 Sep 11. Pharm Res. 2007. PMID: 17846869

10

The use of BDDCS in classifying the permeability of marketed drugs.

Benet LZ, Amidon GL, Barends DM, Lennernäs H, Polli JE, Shah VP, Stavchansky SA, Yu LX. Benet LZ, et al. Among authors: polli je. Pharm Res. 2008 Mar;25(3):483-8. doi: 10.1007/s11095-007-9523-x. Epub 2008 Jan 31. Pharm Res. 2008. PMID: 18236138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page